GLN-POSACONAZOLE
GLN-POSACONAZOLE
Approved
DIN Number
02542021
Drug Class
Human
Market Date
Oct 4, 2023
Company
HC
glenmark pharmaceuticals canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02542021
AIG Number0152201002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC04 POSACONAZOLE
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification08:14.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
POSACONAZOLEActive
Strength: 100 MG
Monograph: POSACONAZOLE